Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal Pharma announced the company will be partnering with Epirium Bio on a manufacturing relationship for new orphan drugs.
read more
Tuesday, December 21, 2021
Piramal Pharma Limited (PPL) announced an investment of INR101.77cr in Yapan Bio Pvt Ltd (“Yapan”) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (...
read more
Wednesday, March 29, 2023
Piramal Pharma Solutions announced that the company has completed the successful integrated development and manufacturing of drug substance and drug product for Brenzavvy™ (bexagliflozin), TheracosBio’s recently approved treatment for type 2 diabetes...
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
Wednesday, November 19, 2025
Piramal Pharma Solutions announced that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
read more
Piramal Pharma Limited's Pharma Solutions business announced a new production block has come online at the company's drug product site in Pithampur, in the state of Madhya Pradesh, India.
read more
Tuesday, December 19, 2023
Piramal Pharma Solutions (PPS), a key player in Contract Development and Manufacturing Organization (CDMO) services under Piramal Pharma Ltd., has inaugurated its advanced antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland,...
read more
Thursday, August 18, 2016
Ash Stevens, Inc., a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce that the company has been acquired by Piramal Pharma Solutions, a ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
Friday, September 08, 2017
Piramal Pharma Solutions announced the appointment of John Fowler as its Chief Operating Officer.
read more
Piramal Pharma Solutions has announced the appointment of Stuart E. Needleman as its Chief Commercial Officer.
read more
Wednesday, October 18, 2023
Piramal Pharma Limited’s Pharma Solutions (PPS) business announced the launch of a high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
read more
Monday, February 02, 2026
Piramal Pharma Solutions announced the successful development, scale-up, and commercialization of a tablet-in-capsule drug delivery system at its drug product facilities in Pithampur and Ahmedabad, India.
read more
Wednesday, January 05, 2022
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a Contract Research, Development and Manufacturing Organization (CDMO), announced that the company has made a multi-million-dollar investment to create a world-class high-throughput screening ...
read more
Tuesday, January 28, 2020
Piramal Enterprises’ Pharma Solutions business announced plans to expand its Aurora facility in Canada with the addition of a new wing dedicated to manufacturing APIs.
read more